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Abstract
Background: The optimal hemoglobin (Hb) threshold at which to initiate red blood cell (RBC) transfusion in
patients with acute brain injury is unknown. The aim of this survey was to investigate RBC transfusion practices
used with these patients.
Methods: We conducted a web-based survey within various societies of critical care medicine for intensive care
unit (ICU) physicians who currently manage patients with primary acute brain injury.
Results: A total of 868 responses were obtained from around the world, half of which (n = 485) were from
European centers; 204 (24%) respondents had a specific certificate in neurocritical care, and most were specialists in
anesthesiology or intensive care and had less than 15 years of practice experience. Four hundred sixty-six
respondents (54%) said they used an Hb threshold of 7–8 g/dl to initiate RBC transfusion after acute brain injury,
although half of these respondents used a different threshold (closer to 9 g/dl) in patients with traumatic brain
injury, subarachnoid hemorrhage, or ischemic stroke. Systemic and cerebral factors were reported as influencing the
need for higher Hb thresholds. Most respondents agreed that a randomized clinical trial was needed to compare
two different Hb thresholds for RBC transfusion, particularly in patients with traumatic brain injury, subarachnoid
hemorrhage, and ischemic stroke.
Conclusions: The Hb threshold used for RBC transfusion after acute brain injury was less than 8 g/dl in half of the
ICU clinicians who responded to our survey. However, more than 50% of these physicians used higher Hb
thresholds in certain conditions.
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Background
Anemia is highly prevalent during critical illness; 60% of
patients admitted to intensive care units (ICUs) are con-
sidered anemic, and 20–30% have a first hemoglobin
(Hb) concentration less than 9 g/dl [1]. Moreover, after a
1-week ICU stay, up to 80% of patients will have Hb
concentrations below this value [2]. Cohort studies have
suggested a strong association between anemia and poor
outcome in heterogeneous populations of critically ill
patients [3, 4], especially among those with a history of
cardiovascular disease [5]. However, the optimal thresh-
old to trigger red blood cell (RBC) transfusion in ICU
patients is not clearly established and may depend on
other confounders related to the underlying disease or
to patient characteristics.
It has been shown that tissue oxygen delivery (DO2) is
dependent on organ blood flow and arterial oxygen con-
tent, which includes the Hb concentration and its oxy-
gen saturation [6]. Thus, during anemia, an increase in
local blood flow or in oxygen extraction is necessary to
maintain adequate DO2 and avoid tissue hypoxia. In
healthy conditions, brain tissue has a high oxygen ex-
traction rate, which may limit its ability to further com-
pensate for reduced DO2 [7]. Thus, cerebral vasodilation
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and increased cerebral blood flow (CBF) are the main
adaptive responses observed in the brain during anemia.
In healthy volunteers, acute isovolemic anemia with Hb
concentrations around 5 g/dl was associated with cogni-
tive deficits and impaired central processing, suggesting
that maximal vasodilation had been achieved at these
Hb concentrations and that no further increase in CBF
could be obtained to compensate for reduced DO2 [8].
However, in acute brain injury, cerebral oxygen con-
sumption may already be increased and cerebral vaso-
dilation may be severely impaired, so that brain hypoxia
could occur at higher Hb concentrations.
Several clinical studies have suggested that Hb concen-
trations less than 9 g/dl are associated with tissue hyp-
oxia, metabolic crises, and poor outcomes among
patients with traumatic brain injury (TBI), subarachnoid
hemorrhage (SAH), or intracranial hemorrhage (ICH)
[9–11]. However, in the same setting, RBC transfusion
has been associated with poor neurological recovery [12,
13]. Thus, assessment of the risk/benefit ratio for trans-
fusion is a key consideration in critically ill patients with
acute brain injury [14]. Transfusion practice has moved
toward more restrictive strategies in critically ill patients
(i.e., to keep Hb ≥7 g/dl) in recent years; however, more
liberal targets (e.g., Hb ≥9 g/dl) are recommended in pa-
tients with underlying cardiovascular disease [15]. Al-
though this approach may also be logical in patients
with acute brain injury, as was recommended in recent
guidelines (i.e., to keep Hb between 8 and 10 g/dl) [2,
16], patients with acute brain injury were poorly repre-
sented in large clinical trials of RBC transfusion strat-
egies, and further clinical investigation is needed in
these patients.
To better understand the feasibility of such studies
and how to develop future therapeutic protocols, it is
important to assess transfusion practice of ICU physi-
cians who manage patients with acute brain injury. Two
surveys of transfusion practice in patients with TBI and
SAH have been published [17, 18], but they were limited
to cohorts of physicians in North America. Thus, the
aim of this survey was to investigate, at a more global
level, the management of anemia and RBC transfusion
practice, including the Hb threshold for transfusion, in
patients with acute brain injury.
Methods
This study was approved and endorsed by the European
Society of Intensive Care Medicine (ESICM) Research
Committee. No ethical approval was needed for the par-
ticipating physicians.
Study design and administration
We conducted a web-based survey sent by email to all
members of the ESICM, the Neurocritical Care Society,
the Australian and New Zealand Intensive Care Society,
the Società Italiana di Anestesia Analgesia Rianimazione
e Terapia Intensiva, and the Brazilian Society of Critical
Care (the questionnaire was not translated). The first
email was sent on 21 May 2013, with two reminders sent
2 and 4 weeks thereafter, respectively. We did not specif-
ically limit the survey to physicians working in academic
institutions; our target sampling was intensivists who
regularly care for patients with acute brain injury (i.e.,
neurointensivists, vascular neurosurgeons, neurologists)
or with extensive interest and experience in the manage-
ment of patients with acute brain injury. The survey was
self-administered by the respondents, voluntary, and
submitted online using a SurveyMonkey system (Survey-
Monkey, San Mateo, CA, USA). No reimbursement was
offered for questionnaire completion. All responses were
anonymous.
Survey development
The survey was developed by two investigators (FST, MO)
on the basis of a review of the relevant literature in this
field. The questionnaire was presented at the Neuro-
Intensive Care Section of the ESICM meeting in October
2012 and sent by email to all participants of this section to
obtain further input. A consensus was then achieved, and
the final version of the survey was sent to the ESICM Re-
search Committee, which gave its final endorsement after
a peer review process (i.e., two reviewers).
The survey was constructed using 24 multiple-choice
questions (Additional file 1: Appendix 1) to evaluate phy-
sicians’ preferences for correcting anemia in patients with
acute brain injury. We also recorded details of ICU and
physician characteristics (i.e., country, specialty, position,
years since completion of training, type of ICU, primary
and secondary specialties, number of ICU beds, hospital
size, and characteristics). We asked the respondents which
Hb threshold they used to trigger RBC transfusion in pa-
tients with acute brain injury and whether the type of dis-
ease, patient characteristics, or specific conditions (e.g.,
increased intracranial pressure or vasospasm) would mod-
ify these thresholds. We also asked about the diagnosis
and management of low iron levels and about the admin-
istration of erythropoietin. Finally, we asked clinicians
about the potential risks and benefits of RBC transfusion
in this setting and whether they believed a clinical trial
should be conducted to specifically determine the optimal
Hb threshold in this patient population. The survey was
not specifically tested in a pilot cohort of potential respon-
dents but underwent a peer review process within the
ESICM Research Committee.
Definitions
We planned a priori to determine how transfusion prac-
tices might be influenced by geographical factors and
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categorized five world areas (Europe, North America,
Central and South America, Asia/Africa, and Oceania).
We also categorized Hb thresholds as a binary variable:
less than 9 g/dl or greater than or equal to 9 g/dl. We
defined the factors that could influence RBC transfusion
policy as noncerebral (e.g., active bleeding, coronary ar-
tery disease[CAD], low mixed venous oxygen saturation
[SvO2], age, lactate level greater than 2.5 mEq/L) or
cerebral (e.g., low brain tissue pressure levels [PbtO2 less
than 15 mmHg], delayed cerebral ischemia [DCI], data
from other neuromonitoring tools [including electroen-
cephalography, noninvasive cerebral oxygenation, trans-
cranial Doppler], presence of intracranial hypertension,
Glasgow Coma Scale score less than 9). Types of acute
brain injury were separated as follows: TBI, SAH, ische-
mic stroke, ICH, postneurosurgery, seizure and status
epilepticus (SE), hypoxic-ischemic encephalopathy (HIE),
central nervous system (CNS) infections, and noninfec-
tious and autoimmune encephalitis.
Statistical analysis
Discrete variables are expressed as count (percent) and
continuous variables as median (IQR or range, as indi-
cated). Differences between study groups were assessed
using a chi-square test, Fisher’s exact test, Kruskal-
Wallis test, or Mann-Whitney U test as appropriate. We
performed multivariable logistic regression analyses to
identify whether the following issues could be explained
by the respondent’s primary specialty (internal medicine,
intensive care, anesthesiology, neurology, surgery, or
pediatrics), the period since completion of training
(years of practice), the type of ICU (medical, neuro-ICU,
surgical), or institution (university, university-affiliated,
non-university-affiliated) rather than the geographical
difference itself: (a) the Hb threshold used to initiate
RBC transfusion after acute brain injury, (b) use of non-
cerebral vs. cerebral factors to adjust the Hb threshold
for transfusion, and (c) the concentration of Hb used to
initiate RBC transfusion in the presence of one or more
influencing factors. The collinearity between variables
was checked by inspection of the correlation between
them, by looking at the correlation matrix of the esti-
mated parameters, and by looking at the change of para-
metric estimates and at their estimated standard errors.
No instability of parametric estimates or an excessive in-
crease of standard errors was observed during the ana-
lyses. A Hosmer-Lemeshow goodness-of-fit test was
considered to assess model calibration (agreement be-
tween observed outcomes and predictions). Q–Q plots
were drawn to check for normality in the residuals. Re-
sults are given as ORs and their 95% CIs. Statistical ana-
lyses were performed using the IBM SPSS Statistics 24.0
for Windows NT software package (IBM, Armonk, NY,
USA). All reported p values are two-sided. A p value less
than 0⋅05 was considered to indicate statistical
significance.
Results
Survey response and demographic characteristics
A total of 868 completed surveys were obtained from the
five regions, 55% of which (n = 485) were from European
ICUs (Additional file 1: Appendix 2 and Additional file 2:
Figure S1). The countries with more respondents were
Italy (n = 133), the United States (n = 129), the United
Kingdom (n = 69), Switzerland (n = 58), and Australia (n =
57). Almost one-fourth of respondents (n = 204 [24%])
had a specific certificate in neurocritical care (Table 1),
with the highest proportion observed in North America.
Most respondents (n = 729 [84%]) were specialists in
anesthesiology or critical care (Table 1); a high proportion
of respondents from North America said their primary
specialty was neurology. Overall, only 20% of the respon-
dents worked in a specialized neuro-ICU, but this propor-
tion was significantly higher in North America than in
other areas. Respondents from North America reported
larger numbers of available ICU beds, more total patients,
and more patients with acute brain injury admitted to the
ICU on the day of the survey.
Transfusion thresholds
More than half the respondents (n = 466 [54%]) stated
that an Hb threshold of 7 or 8 g/dl to initiate RBC trans-
fusion in patients with acute brain injury is used in their
ICUs (Fig. 1, Additional file 2: Table S1). The lowest pro-
portion of respondents who reported that they initiated
RBC transfusion for Hb thresholds less than or equal to
8 g/dl came from Europe and North America (both
49%), whereas in Oceania, this strategy was used by 69%
of respondents. When only respondents providing a spe-
cific Hb threshold were considered, Central and South
American respondents used a lower Hb threshold than
did those from Europe; similarly, respondents from
Oceania used a lower threshold than those from Europe
and Asia/Africa (Additional file 2: Figure S2).
A total of 435 (57%) of 764 of the respondents re-
ported that they used a different Hb threshold for RBC
transfusion in patients with acute brain injury following
TBI (n = 349), SAH (n = 279), ischemic stroke (n = 181),
and HIE (n = 109), whereas only a few considered that a
different transfusion policy was needed for patients with
ICH (n = 88), postneurosurgery (n = 88), seizure/SE (n =
33), CNS infections (n = 27), or encephalitis (n = 18). Re-
spondents more frequently replied that an Hb concen-
tration of 9 g/dl to initiate RBC transfusion was optimal
in TBI (50%), SAH (43%), and ischemic stroke (38%)
than in the setting of other conditions (Fig. 2,
Table 2; Additional file 2: Table S1).
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Table 1 Characteristics of respondents and their intensive care units
Overall (n =
868)
Europe (n =
485)
North America (n
= 140)
Central and South America
(n = 87)
Asia/Africa (n
= 88)
Oceania (n =
68)
p
Value
Certificate <0.001
Neurocritical care, n (%) 77 (9) 11 (3) 59 (42) 4 (5) 3 (3) –
Critical care, n (%) 532 (61) 321 (66) 32 (23) 63 (72) 61 (69) 55 (81)
Both, n (%) 127 (15) 75 (15) 31 (22) 12 (14) 5 (6) 4 (5)
None, n (%) 132 (15) 78 (16) 18 (13) 8 (9) 19 (22) 9 (13)
Primary specialty <0.001
Anesthesiology, n (%) 234 (27) 186 (38) 7 (5) 7 (8) 32 (36) 2 (3)
Intensive care, n (%) 495 (57) 270 (56) 54 (39) 65 (75) 41 (47) 65 (96)
Internal medicine, n (%) 36 (4) 12 (2) 10 (7) 7 (8) 7 (8) –
Neurology, n (%) 70 (8) 5 (1) 57 (41) 5 (6) 3 (3) –
Pediatrics, n (%) 12 (1) 9 (2) 1 (1) – 1 (1) 1 (1)
Surgery, n (%) 21 (2) 3 (1) 11 (8) 3 (3) 4 (5) –
Years of practice 0.07
<5, n (%) 158 (18) 88 (18) 41 (29) 14 (16) 15 (17) –
5–10, n (%) 241 (28) 132 (27) 33 (24) 23 (26) 35 (40) 18 (26)
11–15, n (%) 187 (22) 98 (20) 28 (20) 23 (26) 21 (24) 17 (25)
16–20, n (%) 117 (13) 71 (15) 14 (10) 10 (11) 7 (8) 15 (22)
21–25, n (%) 86 (10) 56 (12) 8 (6) 9 (10) 3 (3) 10 (15)
>25, n (%) 79 (9) 40 (8) 16 (11) 8 (9) 7 (8) 8 (12)
Type of ICU <0.001
Neuro-ICU, n (%) 170 (20) 48 (10) 98 (70) 15 (17) 9 (10) –
Medical ICU, n (%) 46 (5) 20 (4) – 9 (10) 15 (17) 2 (3)
Surgical ICU, n (%) 75 (9) 54 (11) 7 (5) 3 (3) 11 (13) –
Mixed ICU, n (%) 550 (63) 346 (71) 33 (24) 58 (67) 51 (58) 62 (91)
Pediatric ICU, n (%) 27 (3) 17 (4) 2 (1) 2 (3) 2 (2) 4 (6)
Responsible for patients with ABI in the ICU <0.001
Anesthesiologist, n (%) 76 (9) 67 (14) 1 (1) – 8 (9) –
Intensivist, n (%) 494 (57) 311 (64) 57 (40) 43 (50) 26 (30) 57 (84)
Neurologist, n (%) 13 (1) 2 (1) 5 (4) 2 (2) 4 (5) –
Neurosurgeon, n (%) 26 (3) 4 (1) 7 (5) 5 (6) 10 (11) –
Mixed responsibility, n (%) 259 (30) 101 (21) 70 (50) 37 (43) 40 (45) 11 (17)
Number of available ICU beds (on the day of
the survey)
14 [10–22] 12 [8–18] 20 [16–27] 13 [10–20] 15 [10–25] 18 [12–23] <0.001
Hospital size (beds) <0.001
<500, n (%) 345 (40) 175 (36) 40 (29) 65 (75) 39 (44) 26 (38)
500–750, n (%) 208 (24) 107 (22) 39 (28) 16 (18) 18 (20) 28 (41)
751–1000, n (%) 171 (20) 99 (20) 41 (29) 3 (3) 16 (18) 12 (18)
>1000, n (%) 144 (17) 104 (21) 20 (14) 3 (3) 15 (17) 2 (3)
Type of institution <0.001
University, n (%) 341 (39) 205 (42) 84 (60) 12 (14) 25 (28) 15 (22)
University-affiliated, n (%) 241 (28) 109 (22) 27 (19) 27 (31) 29 (33) 49 (72)
Non-university-affiliated, n (%) 286 (33) 171 (35) 29 (21) 48 (55) 34 (39) 4 (6)
Patients on the day of survey, n (%) 12 [8–19] 10 [8–16] 16 [12–20] 12 [8–18] 12 [10–24] 14 [10–21] <0.001
Patients with ABI on day of survey, n (%) 3 [2–6] 3 [1–5] 10 [4–13] 4 [2–6] 4 [2–8] 3 [2–4] <0.001
ABI Acute brain injury, ICU Intensive care unit
Data are presented as count (percent) or median [IQR]
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Overall, noncerebral factors, such as known CAD (n =
474), active bleeding (n = 462), and low SvO2 (n = 393),
were more often reported to influence the Hb threshold
for transfusion than cerebral factors (Additional file 2:
Table S1 and Figure S3). However, cerebral factors
represented 40% of the potential determinants of RBC
transfusion threshold change in North America, whereas
this proportion was significantly lower on other conti-
nents, with the lowest value being in Oceania (17%)
(Additional file 2: Figure S4). In the presence of any of
Fig. 1 Number of respondents (n) for the recommended threshold of hemoglobin (Hb) used to initiate red blood cell transfusion (RBCT) in
patients with acute brain injury
Fig. 2 Proportion of respondents (%) for the different thresholds of hemoglobin used to initiate blood transfusion according to different cerebral
pathologies. SAH Subarachnoid hemorrhage, TBI Traumatic brain injury, Isch stroke Ischemic stroke, ICH Intracranial hemorrhage, NS Neurosurgery
SE Status epilepticus, HIE Hypoxic-ischemic encephalopathy, CNS Infect Infections of the central nervous system
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these factors, 497 (57%) of 868 of respondents said they
would increase the Hb threshold to initiate RBC transfu-
sion to 9 or 10 g/dl (Additional file 2: Table S1and Fig-
ure S5). When only respondents providing a specific
Hb threshold were considered, the Hb threshold to
initiate transfusion was significantly higher when one
or more influencing factors was present than when
they were not (Fig. 3).
The main reason reported for giving a transfusion to a
patient with acute brain injury was the potential increase
in DO2 to ischemic regions (n = 625 [72%]) (Additional file
2: Table S1). Thirty percent of respondents said they
would check the length of RBC storage before transfusion,
but only one-third of these respondents would limit the
administration of “old” RBC units. Only 76 of the respon-
dents reported the maximum duration of RBC storage
allowed for transfusion (median 15; range 2–150). Only
20% (n = 176) of respondents would give non-leukocyte-
depleted RBC units to patients with acute brain injury.
The main reasons given for limiting transfusions in all
patients with acute brain injury were the risk of
transfusion-related acute lung injury (18%), risk of infec-
tion (17%), and altered immune response (14%) (Add-
itional file 2: Table S1). More than 60% of respondents
(n = 523) thought that a randomized clinical trial (RCT)
comparing a restrictive and a liberal transfusion strategy
was necessary in the setting of acute brain injury (Add-
itional file 2: Figure S6); 306 (59%) respondents thought
this study should compare two different Hb thresholds
for initiating transfusion, and 217 (41%) thought it
should compare a restrictive strategy with a strategy guided
by neuromonitoring (e.g., PbtO2 or noninvasive cerebral oxy-
gen saturation). The forms of acute brain injury that should
be included in this study were, in particular, SAH (n= 592)
and TBI (n= 560), whereas the need for such a study was
considered less relevant for ischemic stroke (n= 354) or
hemorrhagic stroke (n = 275), HIE (n = 211), postneur-
osurgery patients (n = 133), seizure/SE (n = 79), CNS
infection (n = 79), or encephalitis (n = 66).
Other issues
Few respondents measured iron levels before RBC trans-
fusion in their clinical practice, except in North America
and Asia/Africa, where more than 10% of those who
responded stated that iron levels were checked in more
than 50% of patients (i.e., frequently or often) (Add-
itional file 2: Table S1). Three hundred three (41%) of
738 respondents (130 did not answer this question) gave
iron supplements to patients with anemia who had acute
brain injury (always, n = 17; only if the ICU length of
stay was longer than 1 week, n = 43; only if iron levels
were reduced, n = 200; only if patients received more
than 8 RBC units, n = 14; only if no signs of infection, n
= 29). Nearly 40% of respondents would frequently or
often check for the presence of chronic anemia in pa-
tients with acute brain injury before initiating transfu-
sion, with similar response rates across regions
(Additional file 2: Table S1). More than 80% of respon-
dents said they did not use erythropoietin (EPO) in pa-
tients with acute brain injury (Additional file 2: Table
S1); among those who would give such therapy, EPO
was used more in TBI (n = 83) and SAH (n = 62) than in
other diseases (HIE, n = 46; ischemic stroke, n = 39; after
neurosurgery, n = 25; ICH, n = 21; CNS infection or en-
cephalitis, n = 18 each; seizure and/or SE, n = 10).
Table 2 Optimal hemoglobin threshold that respondents would use to initiate transfusion for different forms of acute brain injury
Optimal Hb threshold to
initiate RBCT
SAH (n =
698)
TBI (n =
704)
IS (n =
694)
ICH (n =
693)
NS (n =
655)
Seizure/SE (n =
596)
HIE (n =
659)
CNS Inf (n =
594)
Enceph (n =
582)
7 g/dl, n (%) 163 (23) 152 (22) 163 (24) 195 (28) 216 (33) 241 (40) 203 (31) 247 (42) 250 (43)
8 g/dl, n (%) 232 (33) 200 (28) 266 (38) 291 (42) 264 (40) 206 (35) 250 (38) 204 (34) 199 (34)
9 g/dl, n (%) 167 (24) 159 (23) 103 (15) 85 (12) 77 (12) 65 (11) 84 (13) 63 (11) 60 (10)
10 g/dl, n (%) 116 (17) 167 (24) 138 (20) 100 (14) 71 (11) 57 (10) 94 (14) 52 (9) 47 (8)
>10 g/dl, n (%) 5 (1) 12 (2) 9 (1) 5 (1) 8 (1) 9 (2) 11 (2) 8 (1) 4 (1)
Others, n (%) 15 (2) 14 (2) 15 (2) 17 (2) 19 (3) 18 (3) 17 (3) 20 (3) 22 (4)
Abbreviations: SAH Subarachnoid hemorrhage, TBI Traumatic brain injury, IS Ischemic stroke, ICH Intracranial hemorrhage, SE Status epilepticus, HIE Hypoxic-
ischemic encephalopathy, CNS Infect Infections of the central nervous system, Enceph Encephalitis, Hb Hemoglobin, RBCT Red blood cell transfusion
p < 0.001 for trend among groups
Fig. 3 Median normal hemoglobin (Hb) values and altered values in
the presence of trigger factors
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Multivariable analysis
In multivariable analysis, the selection of Hb threshold
to initiate RBC transfusion was significantly determined
by regions (Asia/Africa and Oceania were significantly
associated with a more conservative threshold when
compared with Europe) and physicians’ characteristics
(anesthesiologists were significantly more likely to use a
liberal Hb threshold than were intensivists or physicians
in intensivist-run ICUs) (Additional file 2: Table S2).
Neurologists were more likely to state that noncerebral
factors influenced their decision to transfuse than were
intensivists, as were physicians working in large hospitals
(750–1000 beds) compared with smaller hospitals.
Physicians working in ICUs in which patients with
acute brain injuries were managed by a neurosurgeon
more frequently used cerebral factors to trigger RBC
transfusion than did physicians working in intensivist-
run ICUs. The use of conservative transfusion policies,
even if a trigger factor was present, was more common
in physicians with more than 25 years of practice than in
those with less than 5 years of practice and by physicians
working in ICUs in which patients with acute brain in-
jury were managed by a neurosurgeon compared with
intensivist-run ICUs. Finally, physicians who said they
used cerebral factors to alter transfusion thresholds were
more likely to suggest that a randomized RCT should be
performed to compare a restrictive strategy with a strat-
egy guided by neuromonitoring rather than an RCT
comparing two Hb thresholds.
Discussion
This worldwide survey is the largest to provide data on
the approach of physicians to anemia management and
Hb thresholds for RBC transfusion in patients with acute
brain injury. More than half of the respondents stated
that they used an Hb threshold of 7–8 g/dl to initiate
RBC transfusion after acute brain injury. A lower thresh-
old for transfusion was observed in Africa/Asia and
Oceania than in Europe. However, most respondents
stated that they would increase the Hb trigger threshold
in the presence of various factors, in particular CAD, ac-
tive bleeding, and low SvO2. Most respondents said they
felt an RCT was needed to compare different transfusion
strategies in this patient population, in particular after
SAH and TBI. Respondents’ characteristics that influ-
enced transfusion policies in this setting included their
origin, their background, and their experience, with the
most liberal approaches used by respondents from Eur-
ope and North America, by anesthesiologists and neu-
rologists/neurosurgeons, and by those with less than
5 years in practice.
Only two other surveys have evaluated transfusion
practice in patients with acute brain injury. In the first
study, Sena et al. [17] evaluated responses of 312
physicians, including trauma surgeons, neurosurgeons,
and intensivists from level I trauma centers in the
United States. The authors used two clinical scenarios,
focusing only on TBI. Neurosurgeons reported the high-
est Hb thresholds for initiating RBC transfusion com-
pared with trauma surgeons and intensivists in patients
with normal (8.3 vs. 7.5 vs. 7.5 g/dl, respectively) and el-
evated (8.9 vs. 8.0 vs. 8.4 g/dl, respectively) intracranial
pressure. Interestingly, fewer neurosurgeons than other
physicians reported that they used systemic and cerebral
factors to influence the decision to transfuse. In a sec-
ond study, Kramer et al. [18] performed a survey of 282
academic neurointensivists, neurosurgeons, and multi-
disciplinary intensivists from the United States and
Canada to evaluate transfusion policies for patients with
SAH. The mean Hb concentration used to initiate RBC
transfusion was higher in low-grade patients (8.2 g/dl)
and in those with DCI (8.6 g/dl), with large variability in
the proposed ranges. Again, neurosurgeons expressed
the highest minimum Hb goals compared with other
physicians. Respondents were more likely to transfuse
patients with low PbtO2 values and high brain lactate-
to-pyruvate ratios. Similarly, we also found that most of
the respondents used an Hb threshold of 7–8 g/dl to ini-
tiate RBC transfusion in patients with acute brain injury,
although nearly 60% of these respondents used a higher
threshold in patients with TBI, SAH, and ischemic
stroke.
Nevertheless, in our study, we made some interesting
observations that were not reported in the previous sur-
veys. First, Hb thresholds were more liberal among anes-
thesiologists than among intensivists. This may appear
to be in contrast to recent guidelines from the American
Society of Anesthesiologists suggesting the need for re-
strictive transfusion criteria to minimize RBC use with
no additional risks for poor outcome or cardiac, neuro-
logical, or pulmonary complications [19]. Differences in
practice between these two groups of physicians may ex-
plain these findings, with more than half of transfusions
given by anesthesiologists partially initiated as a result of
a physiological trigger (e.g., hypotension, tachycardia,
preexisting anemia) rather than the absolute value of Hb
[20]. Moreover, one study also showed that, in 48,086
surgical patients at a tertiary U.S. academic medical cen-
ter, the target Hb value after transfusion ordered by an
anesthesiologist was 11.7 ± 1.3 g/dl [21]. Second, previ-
ous surveys have been focused only on physicians in
North America, whereas we report that a conservative
(i.e., 7–8 g/dl) threshold of Hb was more often used in
Asia/Africa and Oceania than in Europe to initiate trans-
fusion. The lower threshold used in African and Asian
countries may be due to limited resources and less blood
availability, as well as to shortage of other supplies (e.g.,
bottles, bags) and greater risk of blood contamination
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[22]. The differences between Europe and Oceania may
be explained by national and statewide initiatives in
Australia/New Zealand to encourage implementation of
patient blood management programs as a cost-effective
standard of care in their public health system, whereas
this approach is not entirely integrated into routine
management in Europe [23, 24].
In this survey, we observed that many clinicians did
not initiate RBC transfusion at a fixed Hb threshold, but
adjusted their practice according to the presence of
other factors. In particular, compared with intensivists,
neurologists more frequently used noncerebral trigger
factors, and neurosurgeons used more frequently used
cerebral factors. The presence of systemic factors such
as low SvO2 values has been widely used to trigger RBC
transfusion in critically ill patients with sepsis [25]. RBC
transfusion may also improve microvascular abnormal-
ities associated with sepsis or may contribute to im-
proved tissue oxygenation in patients with high lactate
levels [26, 27]. Similarly, Oddo et al. [10] showed that
only the combination of low Hb concentrations with re-
duced PbtO2 values negatively affected the outcome of
patients with TBI. Thus, decisions regarding when to
transfuse patients with acute brain injury remain difficult
and should be titrated on an individual patient basis.
Biomarkers of impaired systemic or tissue DO2 may help
identify patients who are most likely to benefit from
RBC transfusion in this setting. Heterogeneity in clinical
practice among physicians with different backgrounds
also suggests the need to better evaluate and identify
which biomarkers could be used in this context.
More than 60% of respondents thought that an RCT
comparing a restrictive and a liberal transfusion strategy
was needed, in particular in patients with SAH and TBI.
Interestingly, whereas 40% indicated that one group
should be guided by neuromonitoring, only 13% of all
respondents stated that neuromonitoring influenced
their RBC transfusion policy and that transfusions were
guided mainly by noncerebral events. This finding un-
derlines that the availability of cerebral trigger factors as
a tool to guide transfusion policy may be logistically dif-
ficult because these tools are not widely available. Also,
the optimal threshold to initiate RBC transfusion in crit-
ically ill patients remains unclear, and many physicians
still use predefined Hb values in their practice. Finally, it
is also possible that the limited options provided in the
survey format prevented respondents from providing
other alternatives to an RCT comparing restrictive vs.
liberal transfusion. Although the willingness to evaluate
transfusion practices in the context of a randomized trial
has also been suggested in previous surveys [17, 18], it
remains unclear which threshold could accurately define
a restrictive or a liberal approach. Current guidelines for
RBC transfusion in the critically ill suggest initiating
transfusion when the Hb is less than 7 g/dl because
higher thresholds do not provide additional benefit [28].
Nevertheless, most practitioners would probably adopt a
higher transfusion Hb threshold in patients with acute
coronary syndrome, as well as in those at risk of second-
ary brain injury, such as patients with SAH with DCI or
in patients with severe TBI [11, 29, 30]. However, it re-
mains unclear whether using RBC transfusion to in-
crease Hb concentrations to 9–11 g/dl is a logical
therapeutic decision to improve cerebral oxygenation
and neurological recovery in these patients. Indeed, in
patients with TBI, the increase in PbtO2 after RBC trans-
fusion was generally limited [31, 32]. In patients with
low-grade SAH, each 1.0 g/dl increase in Hb concentra-
tion after transfusion was associated with an increase of
1.4 mmHg in PbtO2, without significant effects on cere-
bral metabolism [33]. In another study, RBC transfusion
resulted in a significant improvement in cerebral
DO2, in particular in those cerebral territories with
the lowest baseline DO2, and these effects were more
significant than those produced by fluid expansion or
vasopressors [34, 35].
Although we observed some differences in Hb thresh-
olds and RBC transfusion practices across regions and
specialties, we could not determine from our survey
whether this was due to discrepancies in local protocols,
lack of compliance with general recommendations, or
other factors that we did not investigate. For example,
we showed that working in large hospitals (for the use of
noncerebral triggers) and a greater degree of seniority
(for the use of a conservative threshold) may influence
the decision to transfuse. Whether these observations re-
flect a different familiarity with published literature on
these issues or just personal practice is difficult to
determine.
This survey has several limitations that need to be ac-
knowledged. First, the validity of the survey depends on
a high response rate among target physicians. Because
the questionnaire was distributed using email addresses
of members of different medical societies, we could not
determine the potential denominator, which may have
resulted in an underpowered analysis. The total number
of potential respondents (i.e., considering the members
of participating critical care societies; a list of respon-
dents per countries is provided in Additional file 1: Ap-
pendix 2) probably exceeded 15,000 people, and this
might significantly limit the external validity/
generalizability of our findings. We did not specifically
contact only physicians who were experts in neurocriti-
cal care, as was the case in previous surveys [17, 18]; we
also allowed other physicians working in general or
mixed ICUs treating these patients to respond, and this
may provide a broader picture of the general manage-
ment of these patients who are admitted to
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nonspecialized ICUs in many countries. Second, survey
development and testing should follow a process of item
generation through a process of a systematic review;
item reduction; pretesting; and pilot testing for clinical
sensibility, reliability, and validity [36]. Our survey was
based on a consensus within experts in the Neuro-
Intensive Care Section of the ESICM, and the prepar-
ation process might have affected comprehensiveness,
clarity, and face validity as well as respondents’ inter-
pretation of questions. Third, as is true for all surveys,
the responses do not necessarily reflect local practice
but personal opinions of the strategy used to manage
RBC transfusion in this setting. A prospective audit col-
lecting data on this topic would be welcome to provide
more real-world data for this therapeutic intervention.
Fourth, we had few respondents from Africa and needed
to consider Asia and Africa as a single group, although
practices may be different in these two areas. Fifth, our
survey was conducted before the publication of a recent
U.S. study evaluating RBC transfusion management in
patients with TBI [37], which showed no differences be-
tween a liberal (Hb less than 10 g/dl) and a restrictive
(Hb less than 7 g/dl) transfusion strategy. It is impossible
to know whether these results would have influenced
the responses in our survey. Finally, because the survey
was conducted anonymously, we could not control
whether several respondents worked at the same center,
which may have influenced the variability and
generalizability of the results.
Conclusions
In this large survey, most physicians reported using a
conservative Hb (7–8 g/dl) to initiate RBC transfusion in
patients with acute brain injury, although half of them
would use a higher Hb threshold after TBI, SAH, and is-
chemic stroke. Both systemic and cerebral factors may
influence the choice of Hb threshold used for transfu-
sion in these patients. Several differences according to
physician specialty and regional areas were identified.
An RCT comparing two different Hb thresholds for RBC
transfusion in this setting would be more than welcome.
Whether the optimal trial design should rely on prede-
fined Hb values to separate the study groups or use spe-
cific thresholds (either cerebral or systemic) remains to
be further clarified.
Additional files
Additional file 1: Appendix 1. Survey questionnaire. Appendix 2:
Number of respondents per countries. (DOCX 37 kb)
Additional file 2: Table S1. Transfusion policies among respondents.
Table S2. Multivariable logistic regression analyses assessing associations
between respondent characteristics and various transfusion policies for
patients with acute brain injury (ABI). Figure S1. Regional distribution of
respondents across continents. Figure S2. Median threshold of
hemoglobin (Hb) recommended to initiate blood transfusion in patients
with ABI in different geographic regions. Figure S3. Number of
respondents reporting that different trigger factors (n) would influence
their decision to initiate blood transfusion in patients with ABI. Figure
S4. Relative proportions of noncerebral and cerebral trigger factors (%)
used to initiate blood transfusion in patients with ABI, according to
geographic region. Figure S5. Number of respondents (n) stating they
would use a new threshold of hemoglobin (Hb) to initiate blood
transfusion in patients with ABI in the presence of a trigger factor. Figure
S6. Number of respondents (n) agreeing with the need for a randomized
clinical trial (RCT) in patients with anemia from patients with ABI. (DOCX
884 kb)
Acknowledgements
This survey was endorsed by the European Society of Intensive Care
Medicine (ESICM).
Funding
No funding was received for this study.
Availability of data and material
The datasets used and/or analyzed during the present study are available
from the corresponding author on reasonable request.
Authors’ contributions
FST, GC, and MO conceived of the study protocol. FST, GC, and MO
participated in the design and coordination of the study. JIS, MA, JL, and RB
participated in data interpretation. RB and FST carried out the literature
search. RB, FST, and MO drafted the manuscript. GC, JIS, JL, and MA revised
the manuscript. All authors read and approved the final manuscript.
Competing interests
The authors declare that they have no competing interests.
Consent for publication
All authors approved the final version of the manuscript and consented to
its publication.
Ethics approval and consent to participate
Not applicable.
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in
published maps and institutional affiliations.
Author details
1Department of Anesthesiology and Surgical Intensive Care, Hospital Clinic
Universitari, Valencia, Spain. 2Department of Intensive Care Medicine, Centre
Hospitalier Universitaire Vaudois (CHUV), Lausanne University Hospital, 1011
Lausanne, Switzerland. 3Division of Vascular Neurology and Neurocritical
Care, Department of Neurology, Baylor College of Medicine, Catholic Health
Initiatives (CHI) Baylor St. Luke’s–Baylor St. Luke’s Medical Center, Houston,
TX, USA. 4Department of Anesthesiology and Intensive Care Medicine,
Catholic University – Fondazione Policlinico Agostino Gemelli University
Hospital, Rome, Italy. 5Intensive Care Services, Royal Brisbane and Women’s
Hospital, Herston, Australia. 6Burns Trauma Critical Care Research Centre,
University of Queensland, Herston, Australia. 7School of Medicine and
Surgery, University of Milano-Bicocca, Monza, Italy. 8Neurointensive Care, San
Gerardo Hospital, Azienda Socio Sanitaria Territoriale (ASST) of Monza, Monza,
Italy. 9Department of Intensive Care, Erasme Hospital, Free University of
Brussels (ULB), Route de Lennik, 808-1070 Brussels, Belgium.
Received: 20 February 2017 Accepted: 31 May 2017
References
1. Walsh TS, Lee RJ, Maciver CR, Garrioch M, Mackirdy F, Binning AR, et al.
Anemia during and at discharge from intensive care: the impact of
restrictive blood transfusion practice. Intensive Care Med. 2006;32:100–9.
Badenes et al. Critical Care  (2017) 21:159 Page 9 of 10
2. Retter A, Wyncoll D, Pearse R, Carson D, McKechnie S, Stanworth S, et al.
Guidelines on the management of anaemia and red cell transfusion in adult
critically ill patients. Br J Haematol. 2013;160:445–64.
3. Hébert PC, Wells G, Blajchman MA, Marshall J, Martin C, Pagliarello G, et al.
A multicenter, randomized, controlled clinical trial of transfusion
requirements in critical care. N Engl J Med. 1999;340:409–17. A published
erratum appears in N Engl J Med. 1999;340:1056.
4. Wu WC, Schifftner TL, Henderson WG, Eaton CB, Poses RM, Uttley G, et al.
Preoperative hematocrit levels and postoperative outcomes in older
patients undergoing noncardiac surgery. JAMA. 2007;297:2481–8.
5. Kulier A, Levin J, Moser R, Rumpold-Seitlinger G, Tudor IC, Snyder-Ramos SA,
et al. Impact of preoperative anemia on outcome in patients undergoing
coronary artery bypass graft surgery. Circulation. 2007;116:471–9.
6. Hare GM, Tsui AK, Ozawa S, Shander A. Anaemia: can we define haemoglobin
thresholds for impaired oxygen homeostasis and suggest new strategies for
treatment? Best Pract Res Clin Anaesthesiol. 2013;27:85–98.
7. Safaeian N, David T. A computational model of oxygen transport in the
cerebrocapillary levels for normal and pathologic brain function. J Cereb
Blood Flow Metab. 2013;33:1633–41.
8. Weiskopf RB, Toy P, Hopf HW, Feiner J, Finlay HE, Takahashi M, et al. Acute
isovolemic anemia impairs central processing as determined by P300
latency. Clin Neurophysiol. 2005;116:1028–32.
9. Pendem S, Rana S, Manno MG, Gajic O. A review of red cell transfusion in
the neurological intensive care unit. Neurocrit Care. 2006;4:63–7.
10. Oddo M, Levine JM, Kumar M, Iglesias K, Frangos S, Maloney-Wilensky E, et
al. Anemia and brain oxygen after severe traumatic brain injury. Intensive
Care Med. 2012;38:1497–504.
11. Kramer AH, Zygun DA, Bleck TP, Dumont AS, Kassell NF, Nathan B.
Relationship between hemoglobin concentrations and outcomes across
subgroups of patients with aneurysmal subarachnoid hemorrhage.
Neurocrit Care. 2009;10:157–65.
12. George ME, Skarda DE, Watts CR, Pham HD, Beilman GJ. Aggressive red
blood cell transfusion: no association with improved outcomes for victims
of isolated traumatic brain injury. Neurocrit Care. 2008;8:337–43.
13. Warner MA, O’Keeffe T, Bhavsar P, Shringer R, Moore C, Harper C, et al.
Transfusions and long-term functional outcomes in traumatic brain injury. J
Neurosurg. 2010;113:539–46.
14. Leroux P. Haemoglobin management in acute brain injury. Curr Opin Crit
Care. 2013;19:83–91.
15. Hebert PC, Wells G, Tweeddale M, Martin C, Marshall J, Pham B, et al. Does
transfusion practice affect mortality in critically ill patients? Transfusion
Requirements in Critical Care (TRICC) Investigators and the Canadian Critical
Care Trials Group. Am J Respir Crit Care Med. 1997;155:1618–23.
16. Napolitano LM, Kurek S, Luchette FA, Corwin HL, Barie PS, Tisherman SA, et
al. Clinical practice guideline: red blood cell transfusion in adult trauma and
critical care. Crit Care Med. 2009;37:3124–57. A published erratum appears
in Crit Care Med. 2010;38:1621.
17. Sena MJ, Rivers RM, Muizelaar JP, Battistella FD, Utter GH. Transfusion
practices for acute traumatic brain injury: a survey of physicians at US
trauma centers. Intensive Care Med. 2009;35:480–8.
18. Kramer AH, Diringer MN, Suarez JI, Naidech AM, Macdonald LR, Le Roux PD.
Red blood cell transfusion in patients with subarachnoid hemorrhage: a
multidisciplinary North American survey. Crit Care. 2011;15:R30.
19. American Society of Anesthesiologists Task Force on Perioperative Blood
Management. Practice guidelines for perioperative blood management: an
updated report by the American Society of Anesthesiologists Task Force on
Perioperative Blood Management. Anesthesiology. 2015;122:241–75.
20. Meier J, Filipescu D, Kozek-Langenecker S, Llau Pitarch J, Mallett S, Martus P, et al.
Intraoperative transfusion practices in Europe. Br J Anaesth. 2016;116:255–61.
21. Frank SM, Savage WJ, Rothschild JA, Rivers RJ, Ness PM, Paul SL, et al.
Variability in blood and blood component utilization as assessed by an
anesthesia information management system. Anesthesiology. 2012;117:
99–106.
22. Schneider WH. History of blood transfusion in sub-Saharan Africa. Transfus
Med Rev. 2013;27:21–8.
23. Theusinger OM, Felix C, Spahn DR. Strategies to reduce the use of blood
products: a European perspective. Curr Opin Anaesthesiol. 2012;25:59–65.
24. Hofmann A, Farmer S, Towler SC. Strategies to preempt and reduce the use
of blood products: an Australian perspective. Curr Opin Anaesthesiol. 2012;
25:66–73.
25. Rivers E, Nguyen B, Havstad S, Ressler J, Muzzin A, Knoblich B, et al. Early
goal-directed therapy in the treatment of severe sepsis and septic shock. N
Engl J Med. 2001;345:1368–77.
26. Sakr Y, Chierego M, Piagnerelli M, Verdant C, Dubois MJ, Koch M, et al.
Microvascular response to red blood cell transfusion in patients with severe
sepsis. Crit Care Med. 2007;35:1639–44.
27. Sadaka F, Aggu-Sher R, Krause K, O’Brien J, Armbrecht ES, Taylor RW. The
effect of red blood cell transfusion on tissue oxygenation and
microcirculation in severe septic patients. Ann Intensive Care. 2011;1:46.
28. Carson JL, Guyatt G, Heddle NM, Grossman BJ, Cohn CS, Fung MK, et al.
Clinical practice guidelines from the AABB: red blood cell transfusion
thresholds and storage. JAMA. 2016;316:2025–35.
29. Sekhon MS, McLean N, Henderson WR, Chittock DR, Griesdale DE.
Association of hemoglobin concentration and mortality in critically ill
patients with severe traumatic brain injury. Crit Care. 2012;16:R128.
30. Kramer AH, Gurka MJ, Nathan B, Dumont AS, Kassell NF, Bleck TP.
Complications associated with anemia and blood transfusion in patients
with aneurysmal subarachnoid hemorrhage. Crit Care Med. 2008;36:2070–5.
31. Smith MJ, Stiefel MF, Magge S, Frangos S, Bloom S, Gracias V, et al. Packed
red blood cell transfusion increases local cerebral oxygenation. Crit Care
Med. 2005;33:1104–8.
32. Zygun DA, Nortje J, Hutchinson PJ, Timofeev I, Menon DK, Gupta AK. The
effect of red blood cell transfusion on cerebral oxygenation and metabolism
after severe traumatic brain injury. Crit Care Med. 2009;37:1074–8.
33. Kurtz P, Helbok R, Claassen J, Schmidt JM, Fernandez L, Stuart RM, et al. The
effect of packed red blood cell transfusion on cerebral oxygenation and
metabolism after subarachnoid hemorrhage. Neurocrit Care. 2016;24:118–21.
34. Dhar R, Zazulia AR, Videen TO, Zipfel GJ, Derdeyn CP, Diringer MN. Red
blood cell transfusion increases cerebral oxygen delivery in anemic patients
with subarachnoid hemorrhage. Stroke. 2009;40:3039–44.
35. Dhar R, Scalfani MT, Zazulia AR, Videen TO, Derdeyn CP, Diringer MN.
Comparison of induced hypertension, fluid bolus, and blood transfusion to
augment cerebral oxygen delivery after subarachnoid hemorrhage. J
Neurosurg. 2012;116:648–56.
36. Burns KE, Duffett M, Kho ME, Meade MO, Adhikari NK, Sinuff T, et al. A guide
for the design and conduct of self-administered surveys of clinicians. CMAJ.
2008;179:245–52.
37. Robertson CS, Hannay HJ, Yamal JM, Gopinath S, Goodman JC, Tilley BC, et
al. Effect of erythropoietin and transfusion threshold on neurological
recovery after traumatic brain injury: a randomized clinical trial. JAMA. 2014;
312:36–47.
•  We accept pre-submission inquiries 
•  Our selector tool helps you to find the most relevant journal
•  We provide round the clock customer support 
•  Convenient online submission
•  Thorough peer review
•  Inclusion in PubMed and all major indexing services 
•  Maximum visibility for your research
Submit your manuscript at
www.biomedcentral.com/submit
Submit your next manuscript to BioMed Central 
and we will help you at every step:
Badenes et al. Critical Care  (2017) 21:159 Page 10 of 10
